Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

8.990 USD +0.560 (+6.64%)
Streaming Delayed Price Updated: 3:48 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Alimera Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Alimera Sciences Reports Fourth Quarter and 2020 Results
From GlobeNewswire News Releases
Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications
From GlobeNewswire News Releases
Alimera Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021 and Provide Corporate Update
Conference Call to be held Thursday, February 25, 2021 at 9:00am Eastern Time 
From GlobeNewswire News Releases
Alimera Sciences to Present at the Microcap Rodeo Winter Wonderland Conference
From GlobeNewswire News Releases
Alimera Sciences, Inc. Discusses Its 2021 Global Expansion Strategy with The Stock Day Podcast
From Newsfile Corp News Releases
Alimera Sciences Announces Preliminary Top-line Results for Fourth Quarter and Full-Year 2020
From GlobeNewswire News Releases
Alimera Sciences to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
From GlobeNewswire News Releases
Alimera Sciences Announces Launch of ILUVIEN® in the Netherlands
ILUVIEN has been launched for both Diabetic Macular Edema and Non-Infectious Posterior Uveitis Indications 
From GlobeNewswire News Releases
Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference
From GlobeNewswire News Releases
Alimera Sciences Announces Participation at the 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
From GlobeNewswire News Releases
Alimera Sciences Announces Real-World Clinical Data for ILUVIEN® to be Presented at the American Academy of Ophthalmology 2020 Virtual Conference
From GlobeNewswire News Releases
Alimera Sciences Announces Third Quarter 2020 Financial Results
Rebound Continues from COVID Challenges 
From GlobeNewswire News Releases
Alimera Sciences to Report Third Quarter 2020 Financial Results on Wednesday, October 28, 2020 and Provide Corporate Update
Conference Call to be held Thursday, October 29, 2020 at 9:00am Eastern Time 
From GlobeNewswire News Releases
Alimera Sciences Announces Multiple Posters and Papers Highlighting the Durability of ILUVIEN® To Be Presented at the EURETINA 2020 Virtual Congress
From GlobeNewswire News Releases
Alimera Sciences Signs Distribution Agreement With Medis Pharmaceutical to Commercialize Iluvien® in Austria and the Czech Republic
Medis will enable immediate access of ILUVIEN to patients in Austria, and will manage reimbursement negotiations for ILUVIEN in the Czech Republic 
From GlobeNewswire News Releases
UPDATE -- Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
From GlobeNewswire News Releases
Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
From GlobeNewswire News Releases
Alimera Sciences Obtains Reimbursement Approval for ILUVIEN® Use in Non-Infectious Posterior Uveitis in Scotland
Continued execution on strategy to grow international sales of ILUVIEN with new territory approvals, expanded reimbursement of posterior uveitis, and further market penetration 
From GlobeNewswire News Releases
Alimera Sciences Inc. (NASDAQ: ALIM) Featured in Virtual Coverage of The LD 500
From InvestorBrandNetwork
Alimera Sciences Announces Enrollment of First Patient in Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
From GlobeNewswire News Releases
Alimera Sciences Announces National Reimbursement Granted for ILUVIEN® in the Netherlands
ILUVIEN receives pricing and reimbursement approvals for both diabetic macular edema and posterior uveitis indications simultaneously 
From GlobeNewswire News Releases
Alimera Sciences to Present at the LD Micro 500 Virtual Conference on September 2, 2020
From GlobeNewswire News Releases
Alimera Sciences Signs Distribution Agreement With Nordic Prime to Expand International Sales of ILUVIEN® Into Nordic Countries
From GlobeNewswire News Releases
Alimera Sciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Alimera Sciences to Report Second Quarter 2020 Financial Results on Wednesday, July 29, 2020 and Provide Corporate Update
Conference Call to be held Thursday, July 30, 2020 at 9:00 AM Eastern Time 
From GlobeNewswire News Releases
Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
From GlobeNewswire News Releases
Alimera to Present at the June 2020 Virtual Summer Investor Summit
Corporate presentation and live webcast scheduled for June 9, 2020 at 3:55 pm ET 
From GlobeNewswire News Releases
Alimera Sciences Announces First Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Alimera Sciences to Report First Quarter 2020 Financial Results on Wednesday, April 29, 2020 and Provide Corporate Update
Conference Call to be held Thursday, April 30, 2020 at 9:00am Eastern Time 
From GlobeNewswire News Releases
Alimera Sciences Receives $1.8 Million Loan Under the Paycheck Protection Act
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.